Torrent Pharmaceuticals completes amalgamation of J. B. Chemicals & Pharmaceuticals; allots 4.19 crore shares
On 17 July 2026 (record date), Torrent Pharmaceuticals allotted 4,19,22,416 fully paid-up equity shares to eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited pursuant to a Scheme of Amalgamation. The allotment, intimated to NSE on 20 July 2026, represents the completion of the scheme's share-based consideration structure. This merger combines two significant players in the Indian pharmaceutical sector and is governed by the amalgamation scheme as approved by the NCLT and sanctioned under the Companies Act, 2013. The transaction reflects the consolidation trend in mid-cap pharma.
Why it mattersPost-allotment, practitioners must ensure shareholder certification, creditor claims closure, and compliance with NCLT direction on scheme surplus or adjustment mechanisms-precedent on large pharma consolidation under current M&A regulatory architecture.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Announcement Archives · official
- NSE Listed Companies Database · official
- BSE Listed Companies · official
- Ministry of Corporate Affairs (MCA) - NCLT Orders Database · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Time Technoplast Board Approves ₹50 Cr Equity Investment in Time Intercontinental26 Aug 2026 · ₹50 cr
- Mankind Pharma Limited: Other Restructuring26 Aug 2026